Vasa Therapeutics
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Safety, Tolerability, and Biomarker Trial of VS-041 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT07219511) | Vasa Therapeutics | 2025-11-04 |
Track Vasa Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.